title: Pgrmc1: new roles in the microglial mediation of progesterone-antagonism of estradiol-dependent neurite sprouting and in microglial activation.
abstract: Pgrmc1 (progesterone receptor membrane component 1) is a multifunctional 22 kDa protein with heme-binding and P450-activating capacity which was recognized under different names for roles in cell motility during neural development and in cancer, and apoptosis. Pgrmc1 expression in microglia was recently shown by the present authors to mediate estrogen-progesterone interactions during axonal sprouting and to mediate microglial activation itself. We also discuss other functions of Pgramc1 in the nervous system and its possible relationship to the 18 kDa sigma-2 receptor (S2R).
authors.affiliation: Davis School of Gerontology, University of Southern California Los Angeles Los Angeles, CA, USA ; Dornsife College of Letters, Arts and Sciences, University of Southern California Los Angeles Los Angeles, CA, USA.
authors.forename: N
authors.initials: N
authors.lastname: Bali
authors.forename: T E
authors.initials: TE
authors.lastname: Morgan
authors.forename: C E
authors.initials: CE
authors.lastname: Finch
keywords: Prgmc1; S2R; microglia; progesterone; sprouting
references.citation: Endocrinology. 2009 Jan;150(1):324-32
references.pmid: 18772232
references.citation: Front Neurosci. 2013 Jun 13;7:99
references.pmid: 23781168
references.citation: Neuroscience. 2013 Feb 12;231:111-24
references.pmid: 23211561
references.citation: Neuroscience. 2011 Sep 15;191:101-6
references.pmid: 21497181
references.citation: Curr Protein Pept Sci. 2012 Nov;13(7):687-96
references.pmid: 23228349
references.citation: J Pharmacol Exp Ther. 2011 Oct;339(1):161-72
references.pmid: 21715561
references.citation: Endocrinology. 2012 Sep;153(9):4389-400
references.pmid: 22778217
references.citation: Acta Neuropathol. 2006 Oct;112(4):389-404
references.pmid: 16906426
references.citation: Front Neuroendocrinol. 2008 May;29(2):313-39
references.pmid: 18374402
references.citation: Neuroscience. 2011 Jan 13;172:55-65
references.pmid: 20977928
references.citation: Endocrinology. 2013 Jul;154(7):2468-80
references.pmid: 23653459
references.citation: Am J Physiol Cell Physiol. 2011 Feb;300(2):C328-37
references.pmid: 21084640
references.citation: Endocrinology. 2009 Jul;150(7):3186-96
references.pmid: 19359388
references.citation: Neuroscience. 2010 Mar 10;166(1):94-106
references.pmid: 20025939
references.citation: Endocrinology. 2012 Sep;153(9):4457-69
references.pmid: 22822163
references.citation: Mol Cell Endocrinol. 2010 May 14;320(1-2):153-61
references.pmid: 20144686
references.citation: Nat Commun. 2011 Jul 05;2:380
references.pmid: 21730960
references.citation: Science. 2013 Jan 11;339(6116):156-61
references.pmid: 23307732
references.citation: J Steroid Biochem Mol Biol. 2007 Jun-Jul;105(1-5):16-36
references.pmid: 17583495
references.citation: Endocrinology. 2011 Jan;152(1):207-13
references.pmid: 21047944
references.citation: Endocrinology. 2012 Feb;153(2):759-69
references.pmid: 22147012
references.citation: J Pharmacol Exp Ther. 2010 May;333(2):564-73
references.pmid: 20164297
references.citation: J Neurosci. 1992 Jul;12(7):2549-54
references.pmid: 1613547
references.citation: Int J Cancer. 2012 Jul 15;131(2):E1-9
references.pmid: 21918976
references.citation: J Neurochem. 2005 Jun;93(5):1314-26
references.pmid: 15934950
references.citation: Mol Cell Neurosci. 1999 Dec;14(6):428-43
references.pmid: 10656251
references.citation: Glia. 2008 Apr 15;56(6):659-74
references.pmid: 18286612
references.citation: J Neurosci. 2012 Aug 22;32(34):11706-15
references.pmid: 22915113
references.citation: Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12816-21
references.pmid: 11070092